It's time to reimagine reimbursement for CAR T-cell therapy

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions.

Authors

Publication Details

Journal
The American Journal of Managed Care
Published
2025-12-01
DOI
https://doi.org/10.37765/ajmc.2025.89878
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

It's time to reimagine reimbursement for CAR T-cell therapy

Brian O’Rourke, Anna Sureda, Meagan O'Neill
The American Journal of Managed Care
CAR-T cell therapy research
article

It's time to reimagine reimbursement for CAR T-cell therapy

Brian O’Rourke, Anna Sureda, Meagan O'Neill
article en

Abstract

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions.

The American Journal of Managed CareVol. 31(Spec. No. 13)
Openalex Percentile: Top 28%
CAR-T cell therapy research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

It's time to reimagine reimbursement for CAR T-cell therapy — Brian O’Rourke, Anna Sureda, et al. · The American Journal of Managed Care (2025) | TGRS Research Map | TGRS